Dr. Lal Pathlabs shares hit 52-week low post Q4 results; here’s why Dr. Lal Pathlabs has reported a 27% YoY fall in consolidated net profit to ₹62 crore in Q4FY22 due to a decline in revenue from Covid and allied business. By Chitranjan Kumar
